Can Wegovy Give You Pancreatitis? Here's What You Should Know

Step 1: Know what pancreatitis actually feels like on Wegovy

Pancreatitis is inflammation of the pancreas, and the symptom that distinguishes it from ordinary nausea or indigestion is the pain. It tends to be severe and persistent, sitting in the upper abdomen and often radiating through to the back. It can arrive with nausea, vomiting, or both, but the key difference from the usual GI side effects of Wegovy is that it does not ease off after a few minutes or when you change position.

Common Wegovy side effects like nausea, constipation, or burping are real but generally mild and tend to settle over the first couple of weeks of a new dose. Pancreatitis is a different category of event entirely. If the pain is severe and doesn't pass, that is not something to sleep off or wait until the morning to mention to anyone. Get medical help the same day. The NHS medicines page for semaglutide sets out this distinction clearly.

For a broader look at what Wegovy can and cannot cause, our guide to Wegovy side effects covers the full profile in detail.

Step 2: Understand how common (or uncommon) the risk actually is

The clinical data places pancreatitis in the "uncommon" category, meaning it affected fewer than 1 in 100 participants across the trial programme. That is not zero, and it is not something to dismiss, but it is a very different risk level from the nausea that affects a substantial portion of people starting treatment.

The January 2026 MHRA Drug Safety Update reinforced that prescribers should counsel patients on this risk and that the benefit-risk balance remains favourable for eligible patients, but the regulator wanted the warning to be clear and consistent. This is standard pharmacovigilance: a medicine can carry a rare serious risk and still be appropriate for many people, provided the risk is understood. You can read more about the specific causal questions and what research tells us about whether Wegovy causes pancreatitis or whether it surfaces an underlying tendency in some patients.

There is also an open question about timing. If you are wondering how quickly pancreatitis can develop on Wegovy, cases have been reported at various points in treatment, not only at the start, which is why ongoing awareness matters throughout the course, not just in the first few weeks.

Step 3: Know who faces a higher starting risk

Certain factors make pancreatitis more likely regardless of which medicine you take: a personal history of pancreatitis, gallstones, heavy alcohol use, or very high triglycerides. When one of these applies, the prescriber's job is to weigh that context carefully. For people who have had pancreatitis before, the question is not hypothetical. Our page on Wegovy after a previous episode of pancreatitis covers what prescribers look at and what the guidance says.

Worth mentioning: fatigue can accompany many conditions, including those that affect the pancreas. If you are unexpectedly exhausted on Wegovy and it feels different from the tiredness that comes with a dose increase, our page on feeling very tired on Wegovy explores what the causes might be. It is one of the questions our prescribers hear most weeks.

When to get medical help and how to reduce your risk

If you develop severe abdominal pain that persists, spreads to the back, or comes with repeated vomiting, go to A&E or call 999. Do not take another dose until you have been assessed by a doctor. This is not overcaution. Pancreatitis caught early is treated more effectively than pancreatitis that has been going on for hours while someone tries to manage it at home.

Practical steps that may help reduce your risk during treatment: stay well hydrated (dehydration worsens several GI complications), avoid alcohol, and if you have been prescribed Wegovy despite a gallstone history, make sure your prescriber knows the full picture. Our page on how to reduce your pancreatitis risk on Wegovy goes into more detail on the lifestyle factors.

You can report any suspected side effect, including pain that concerns you, to the MHRA via the Yellow Card scheme. Reports from real-world patients are exactly how the MHRA builds its post-market safety picture, and your report matters even if you are not sure the symptom is drug-related.

At nume, a real prescriber reviews your full medical history before any treatment is approved. Pancreatitis risk is one of the things the consultation is specifically designed to surface. If you would like to explore whether Wegovy is suitable for you, speaking to our prescribers is the place to start — and our Wegovy overview covers how the medicine works if you want broader context first.